We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
subclones, raising the possibility to assess the risk of targeted therapy failure.
No takes yet. Share an insight, caveat, or question.
Rabilloud et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: